Journal Papers,
Abstracts, and Commentaries
| |
Diastolic Dysfunction in Individuals with Human Immunodeficiency Virus
Infection: Literature Review, Rationale and Design of the Characterizing Heart
Function on Anti-Retroviral Therapy (CHART) Study.
Butler J, Kalogeropoulos AP, Anstrom KJ, Nickens P, et al
J Card Fail. 2018 Feb 23.
pii: S1071-9164(18)30064-2
Abstract
Changes in Cardiovascular Disease Risk Factors With Immediate Versus
Deferred Antiretroviral Therapy Initiation Among HIV-Positive Participants
in the START (Strategic Timing of Antiretroviral Treatment) Trial.
Baker JV, Sharma S, Achhra AC, et al
J
Am Heart Assoc. 2017 May
Abstract
Effects of Antiretroviral Therapy on Immune Function and Arterial
Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus
Infection.
Zanni MV, Toribio M, Robbins GK, et alJ
AMA Cardiol.
2016 Jul 1;1(4):474-80. .
Abstract
HIV, highly active antiretroviral therapy and the heart: a
cellular to epidemiological review.
Lambert CT, Sandesara PB, Hirsh B,
et al
HIV Med. 2015 Nov 26.
Abstract
FULL-TEXT ARTICLE
Risk Factors of
Cardiovascular Diseases in HIV/AIDS Patients on HAART.
Nsagha DS, Assob JC, Njunda AL, et al
Open AIDS J.
2015 Oct 20;9:51-59
Paper
Risk of Cardiovascular Events Associated with Current Exposure to
HIV Antiretroviral Therapies in a US Veteran Population.
Desai M, Joyce V, Bendavid E, Olshen RA, et al
Clin Infect Dis. 2015 Apr 22.
Abstract
Myocardial Infarction, Stroke, and Mortality in cART-Treated HIV
Patients on Statins.
Krsak M, Kent DM, Terrin N, et al
AIDS Patient Care STDS. 2015 Apr 9.
Abstract
Assessment of arterial elasticity among
HIV-positive participants with high CD4 cell counts: a substudy
of the INSIGHT Strategic Timing of AntiRetroviral Treatment
(START) trial.
Baker J, Engen N, Huppler Hullsiek K, et al
HIV Med. 2015 Apr;16 Suppl
1:109-18
Abstract
QT Dispersion in HIV-Infected Patients Receiving
Combined Antiretroviral Therapy.
Wongcharoen W, Suaklin S, Tantisirivit N,
et al
Ann Noninvasive Electrocardiol.
2014 Apr 21.
Abstract
Perivascular fat, inflammation, and cardiovascular
risk in HIV-infected patients on antiretroviral therapy.
Longenecker CT, Jiang Y, Yun CH, et al
Int J Cardiol.
2013 Jul 22.
Abstract
FULL-TEXT ARTICLE
Risk of Cardiovascular Disease from Antiretroviral Therapy for
HIV: A Systematic Review.
Bavinger C, Bendavid E, Niehaus K, et al
PLoS One.
2013;8(3):e59551
Paper |
Venous and Arterial Thromboembolic Complications Associated with
HIV Infection and
Highly Active Antiretroviral Therapy.
Auerbach E, Aboulafia DM.
Semin Thromb Hemost.
2012 Oct 6.
Abstract
HAART to heart: highly active antiretroviral therapy and the risk
of cardiovascular disease in HIV-infected
or exposed children and adults.
Lipshultz SE, Mas CM, Henkel JM,
et al
Expert Rev Anti Infect Ther.
2012 Jun;10(6):661-74..
Abstract |
Left ventricular remodelling in asymptomatic HIV infection
on chronic HAART: comparison
between hypertensive and normotensive subjects with and
without HIV infection.
Grandi AM, Nicolini E, Giola M, Gianni M,
et al
J Hum Hypertens.
2011 Sep 15
Abstract
Hypertriglyceridemia, Metabolic Syndrome, and Cardiovascular
Disease in HIV-Infected Patients:
Effects of Antiretroviral Therapy and Adipose Tissue
Distribution.
van Wijk JP, Cabezas MC.
Int J Vasc Med.
2012;2012:201027.
Abstract
FULL-TEXT ARTICLE
Decreased Heart Rate Variability in HIV Positive Patients
Receiving Antiretroviral Therapy:
Importance of Blood Glucose and Cholesterol
Askgaard G,
Kristoffersen
US.
Mehlsen J, et al
PLoS One.
201131 May 2011
Paper
Reduction in coronary and peripheral vasomotor function in
patients with HIV after
initiation of antiretroviral therapy: a longitudinal study with
positron emission
tomography and flow-mediated dilation.
Kristoffersen US, Wiinberg N, Petersen CL, et al
Nucl Med Commun.
2010 Aug 7.
Abstract |
Antiretroviral therapy with heart.
Randell P, Moyle G.
Am J Ther. 2009
Nov-Dec;16(6):579-84.
Abstract |
Association of Highly Active
Antiretroviral Therapy With Increased Arterial Stiffness
in
Patients Infected
With Human Immunodeficiency Virus.
Lekakis J, Ikonomidis I, Palios J,et
al
Am J Hypertens.
2009 Jun 25
Abstract |
Human Immunodeficiency Virus and Highly Active Antiretroviral
Therapy-Associated Metabolic Disorders
and Risk Factors for Cardiovascular Disease.
Anuurad E, Semrad A, Berglund L.
Metab Syndr Relat Disord.
2009 Apr 8.
Abstract
|
Highly active antiretroviral therapy-associated metabolic syndrome:
pathogenesis and
cardiovascular risk
Barbaro G.Am
J Ther. 2006 May-Jun;13(3):248-60.
Abstract
Combination antiretroviral therapy and the risk of myocardial infarction.
Friis-Moller N, Sabin CA, Weber R, et al
N Engl J Med. 2003 Nov
20;349(21):1993-2003.
Abstract"
|
Conference Reports, Abstracts, and Posters
Journal Papers,
Abstracts, and Commentaries
|
Journal Papers,
Abstracts, and Commentaries
|
Journal Papers,
Abstracts, and Commentaries
|
| |
Carotid artery thickness is associated with chronic use of highly active
antiretroviral therapy in patients infected with human immunodeficiency
virus: A 3.0 Tesla magnetic resonance imaging study.
LaBounty TM, Hardy WD, Fan Z, et al
HIV Med. 2015 Dec 3.
Abstract
Long-term use of first-line highly active
antiretroviral therapy is not associated with carotid artery
stiffness in human immunodeficiency virus-positive patients.
Zhu
H, Yuan J, Wang Y,
et al
Braz J Infect Dis.
2014 May 9.
Abstract
Plasma Klotho Levels Were Inversely
Associated with Subclinical Carotid Atherosclerosis in
HIV-infected Patients Receiving Combined Antiretroviral
Therapy.
Jeong SJ, Song JE, Kim SB, et al
AIDS Res Hum Retroviruses.
2013 Aug 13.
Abstract
Associations of antiretroviral drug use and HIV-specific
risk factors with
carotid intima-media thickness.
Delaney JA, Scherzer R, Biggs ML,et al
AIDS.
2010 Jul 27.
Abstract |
Increase in Carotid Artery Intima-Media Thickness and Arterial
Stiffness but Improvement in Several
Markers of Endothelial Function after Initiation of Antiretroviral
Therapy.
van Vonderen MG, Hassink EA, van Agtmael MA,
et al
J Infect Dis.
2009 Mar 10.
Abstract |
Journal Papers,
Abstracts, and Commentaries
Journal Papers,
Abstracts, and Commentaries
Journal Papers,
Abstracts, and Commentaries
|
| |
Evidence of increased blood pressure and hypertension risk
among people living with HIV on antiretroviral therapy: a
systematic review with meta-analysis.
Nduka CU, Stranges S, Sarki AM,
et
al
J Hum Hypertens.
2015 Oct 8
Abstract
Left ventricular remodelling in asymptomatic HIV infection
on chronic HAART: comparison
between hypertensive and normotensive subjects with and
without HIV infection.
Grandi AM, Nicolini E, Giola M, Gianni M,
et al
J Hum Hypertens.
2011 Sep 15
Abstract
Impact of highly active antiretroviral therapy on blood pressure in
HIV-infected patients.
A prospective study in a cohort of naive patients.
Palacios R, Santos J, Garcia A, et al
HIV Med. 2006 Jan;7(1):10-5.
Abstract
|
Regression of
HIV-associated pulmonary arterial hypertension and
long-term
survival during antiretroviral therapy.
Speich R, Jenni R, Opravil M, Jaccard R.
Swiss Med Wkly 2001 Dec 1;131(45-46):663-5
Abstract |
|
|
|
General
Reports 
Lipid
Disorders
Documents identified with this icon are in Portable Document Format (PDF)
and require the
Adobe
Acrobat Reader